Vascular endothelial growth factor (VEGF) expression in the subacromial bursa is increased in patients with impingement syndrome
β Scribed by K. Yanagisawa; K. Hamada; M. Gotoh; T. Tokunaga; Y. Oshika; M. Tomisawa; Y. Hwan Lee; A. Handa; H. Kijima; H. Yamazaki; M. Nakamura; Y. Ueyama; N. Tamaoki; H. Fukuda
- Book ID
- 108456956
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 884 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between
## Abstract **Background/aims** Vascular endothelial growth factor (VEGF) is a cytokine participating in inflammation with potent endothelial cell effects. It is produced by macrophages, neutrophils and vascular endothelial cells and can alter vessel permeability. BehΓ§et's syndrome is a systemic in